Back

Improvement of mitral regurgitation following transcatheter aortic valve implantation: outcomes and predictors in a retrospective cohort study

19 May 2025 (15:00 - 15:45)
Organised by: Logo
Congress Presentation Part of: Interventional cardiology Aortic Valve Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Marta Paralta De Figueiredo

Hospital Espirito Santo de Evora, Evora (Portugal)

6 More presentations in this session

Presentation thumbnail
One-year right heart failure outcomes in patients with severe tricuspid regurgitation in the TRISCEND II trial
Professor M. Hell (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Preservation dilemma: prognosis across the preserved spectrum of transcatheter aortic valve replacement patients for severe aortic stenosis
Doctor T. Pereira dos Santos (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Antithrombotic therapy after valve-in-valve, valve-in-ring and valve-in-MAC: review and metaanalysis
Doctor G. Terleira Batista (Coimbra, PT) Doctor M. Rodrigues Simoes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
A single-centre perspective on survival and complications after transcatheter aortic valve replacement in chronic kidney disease and end-stage renal disease patients
Doctor T. Pereira dos Santos (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Unlocking recovery: predictors and outcomes of left ventricular dysfunction after TAVI
Doctor S. Esteves (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional cardiology

The Event

Event poster

Heart Failure 2025

19 May 2025 15:00 CET
You may be interested in
thumbnail
Congress Presentation
The effects of surgical and transcatheter aortic valve replacement for aortic stenosis on regression and progression of mitral regurgitation -a propensity score matched analysis
thumbnail
Congress Presentation
Prognostic significance of functional mitral regurgitation in heart failure patients undergoing cardiac resynchronization therapy
thumbnail
Congress Presentation
Post-procedural mitral regurgitation as an independent predictor of morbidity and mortality outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources